NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM171273 Query DataSets for GSM171273
Status Public on Feb 27, 2007
Title ID_19_TimePt_7
Sample type RNA
 
Source name Human PBMC collected from whole blood.
Organism Homo sapiens
Characteristics ID_19_TimePt_7_Race_CA_Resp_Poor
Treatment protocol The clinical protocol called for participants to be treated for up to 48 weeks with peginterferon alpha-2a (Pegasys™, Roche Pharmaceuticals Nutley, NJ) in a dose of 180 µg weekly by self-administered subcutaneous injection and ribavirin (Copegus™, Roche) orally in a dose of 1000 or 1200 mg daily based on body weight of less than 75 kg or equal to or greater than 75 kg.
Extracted molecule total RNA
Extraction protocol Samples were shipped overnight by express courier at 4 degrees C to a central repository where RNA was isolated on arrival The PBMC were lysed in 1 ml of TRI reagent (Molecular Research Center Inc: Cincinnati, OH). The PBMC lysate was mixed with 1-Bromo-3-chloropropane (BCP)-phase separation agent for 1 minute, and incubated at room temperature for 15 minutes. After centrifugation for 15 minutes at 12,000 rpm and 4 degrees C, RNA was precipitated from the supernatant overnight at -20 degrees C with an equal volume of isopropanol and 1/10 volume of 7.5 M-ammonium acetate. The precipitate was washed twice with 75% ethanol, and then with 95% ethanol. RNA was briefly air-dried and then further purified using RNeasy columns (Qiagen: Valencia, CA).
Label biotin
Label protocol Preparation of cDNA, cRNA, and labeling were carried out according to the protocols recommended by Affymetrix in the GeneChip® Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA)
 
Hybridization protocol Following fragmentation, 15 microg of cRNA were mixed with spike controls and 2/3 was hybridized for 17 hr at 45C on GeneChip Human Genome 133A Array. GeneChips were washed and stained in the Affymetrix Fluidics Station per manufacturer's instructions.
Scan protocol The microarrays were scanned using a dedicated Model 3000 scanner controlled by GCOS software.
Description Gene Expression for human subject. Human PBMC collected from whole blood. PBMC were collected in sodium heparin-CPT tubes at day 0 (before treatment) and days 1, 2, 7, 14 and 28 after initiation of treatment. Whole blood was diluted with an equal volume (8 ml) of phosphate buffered saline (PBS), carefully layered over a 10 ml Ficoll-Hypaque gradient (Amersham/Pharmacia, Piscataway, NJ) and centrifuged at 800 rpm for 20 minutes at room temperature. The buffy coat layer was transferred to a 15ml RNAse-free tube, diluted with PBS, and centrifuged at 100 x g for 15 minutes at room temperature. The supernatants were discarded and the PBMC were retained.
Data processing GCOS was used for data processing. The average intensity on each array was normalized by global scaling to a target intensity of 1000. Data were extracted using the Affymetrix Microarray Suite 5 (MAS5) algorithm
 
Submission date Feb 23, 2007
Last update date Feb 27, 2007
Contact name Milton W Taylor
E-mail(s) [email protected]
Organization name Indiana University
Department Biology
Street address 343 Jordan Hall
City Bloomington
State/province IN
ZIP/Postal code 47405
Country USA
 
Platform ID GPL96
Series (1)
GSE7123 Gene profiling of responders and non-responders to antiviral therapies peg interferon and ribavirin against hepatitis C

Data table header descriptions
ID_REF
VALUE MAS5-calculated Signal intensity
ABS_CALL the call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC); default parameters.
DETECTION P-VALUE 'detection p-value', p-value that indicates the significance level of the detection call

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-BioB-5_at 537.5 P 0.000754
AFFX-BioB-M_at 1111 P 0.00006
AFFX-BioB-3_at 408.3 P 0.000127
AFFX-BioC-5_at 1958.4 P 0.00007
AFFX-BioC-3_at 2053.4 P 0.000044
AFFX-BioDn-5_at 2558.6 P 0.000052
AFFX-BioDn-3_at 10244.6 P 0.000127
AFFX-CreX-5_at 20974.9 P 0.000044
AFFX-CreX-3_at 29116.1 P 0.000044
AFFX-DapX-5_at 41.5 A 0.147939
AFFX-DapX-M_at 57.4 A 0.227636
AFFX-DapX-3_at 59.1 A 0.659339
AFFX-LysX-5_at 3.4 A 0.945802
AFFX-LysX-M_at 45.2 A 0.5
AFFX-LysX-3_at 38 A 0.139482
AFFX-PheX-5_at 6.9 A 0.897835
AFFX-PheX-M_at 9.1 A 0.883887
AFFX-PheX-3_at 92 A 0.411373
AFFX-ThrX-5_at 8.8 A 0.83416
AFFX-ThrX-M_at 54.4 A 0.5

Total number of rows: 22283

Table truncated, full table size 599 Kbytes.




Supplementary file Size Download File type/resource
GSM171273.CEL.gz 2.2 Mb (ftp)(http) CEL

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap